![]() |
|
|
Vol. 293, Issue 2, 397-402, May 2000
Department of Physiology and Pharmacology, Loma Linda University,
School of Medicine, Loma Linda, California (E.N.M., L.Z., J.B.); and
Department of Pharmacology, College of Medicine, University of
California, Irvine, California (S.P.D.)
Cerebral blood vessels contain both sympathetic and nitric oxide (NO)
synthase (NOS)-containing nerves. NO has been proposed to modulate
smooth muscle function and adrenergic nerve activity, and the nature of
this modulation is controversial: some data show NO inhibits
norepinephrine (NE) release, whereas others suggest that NO augments
release. To test the hypothesis that in cerebral arteries NO released
by NOS-containing nerves augments stimulation-evoked NE release, we
used direct measurement of NE and NO release in isolated sheep middle
cerebral arteries. The facial artery, which has not been reported to be
innervated with NOS-containing nerves, was used as an artery comparison
model. HPLC and redox electrochemical detection was used to measure NE,
and NO was measured by chemiluminescence. Stimulation-evoked NE release
from the middle cerebral artery significantly declined in the presence
of the NOS inhibitor
N
-nitro-L-arginine methyl
ester (L-NAME). The effect of
L-NAME was reversed by the addition of the NO donor
S-nitroso-N-acetyl-DL-penicillamine. In contrast, in facial arteries, L-NAME had no effect
on stimulation-evoked NE release, whereas
S-nitroso-N-acetyl-DL-penicillamine
still significantly elevated NE release. Activation of perivascular nerves significantly increased NE release in both the middle cerebral and facial arteries. However, when NO was measured in the same samples,
stimulation-evoked release of NO was significantly increased compared
with basal release only in middle cerebral arteries. These data support
the concept that cerebral arteries in the sheep contain both adrenergic
and NOS-containing nerves. Furthermore, this study provides succinct
evidence that NO released from NOS nerves augments stimulation-evoked
NE release.
This article has been cited by other articles:
![]() |
C. K. Vanterpool, E. A. Vanterpool, W. J. Pearce, and J. N. Buchholz Advancing age alters the expression of the ryanodine receptor 3 isoform in adult rat superior cervical ganglia J Appl Physiol, August 1, 2006; 101(2): 392 - 400. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Toda and T. Okamura The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels Pharmacol. Rev., June 1, 2003; 55(2): 271 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Mbaku, L. Zhang, W. J. Pearce, S. P. Duckles, and J. Buchholz Chronic hypoxia alters the function of NOS nerves in cerebral arteries of near-term fetal and adult sheep J Appl Physiol, February 1, 2003; 94(2): 724 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Bishai, L. Penninga, R. Nijland, R. Meulenaar, C. P. Gheorghe, Y. Zhao, J. N. Buchholz, L. Zhang, and L. D. Longo Pre- and postjunctional alpha 2-adrenergic receptors in fetal and adult ovine cerebral arteries Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1654 - R1662. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Buchholz and S. P. Duckles Chronic hypoxia alters prejunctional {alpha}2-receptor function in vascular adrenergic nerves of adult and fetal sheep Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2001; 281(3): R926 - R934. [Abstract] [Full Text] [PDF] |
||||